Clinical Trial Update: Serial Changes of Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) Levels in Patients With Acute Respiratory Distress Syndrome

View source ↗

Summary

This document describes a completed clinical trial evaluating serial changes in soluble TREM-1 levels in patients with acute respiratory distress syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Acute Respiratory Distress Syndrome | Status: COMPLETED